These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 1351927)

  • 21. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential modulation of D1 and D2 dopamine-sensitive adenylate cyclases by 17 beta-estradiol in cultured striatal neurons and anterior pituitary cells.
    Maus M; Bertrand P; Drouva S; Rasolonjanahary R; Kordon C; Glowinski J; Premont J; Enjalbert A
    J Neurochem; 1989 Feb; 52(2):410-8. PubMed ID: 2521359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of EEDQ on the dopamine D-1 receptor in vivo and in vitro.
    Andersen PH
    Eur J Pharmacol; 1988 Jul; 152(1-2):153-6. PubMed ID: 2905267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats.
    Zou LL; Liu J; Jin GZ
    Biochem Pharmacol; 1997 Jul; 54(2):233-40. PubMed ID: 9271327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Saller CF; Kreamer LD; Adamovage LA; Salama AI
    Life Sci; 1989; 45(10):917-29. PubMed ID: 2529407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):273-7. PubMed ID: 2110042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of dopamine binding sites and changes in dopamine and dihydroxyphenylacetic acid levels in 17- and 90-day-old rat striatum after irreversible receptor antagonism.
    Crawford CA; McDougall SA; Rowlett JK; Bardo MT
    Neurosci Lett; 1992 Mar; 137(2):265-9. PubMed ID: 1350079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
    Kula NS; George T; Baldessarini RJ
    Brain Res Dev Brain Res; 1992 Apr; 66(2):286-9. PubMed ID: 1535031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats chronically treated with haloperidol.
    Hatta Y; Hatta S; Saito T
    Psychopharmacology (Berl); 1993; 110(4):383-9. PubMed ID: 7870906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW; Creese I
    Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
    Olianas MC; Onali P
    J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between the occupation of the D-1 dopamine receptor by [3H]piflutixol and the activity of dopamine-sensitive adenylate cyclase in rat striatal membranes.
    Fleminger S
    Biochem Pharmacol; 1991 Jul; 42(2):229-37. PubMed ID: 1650205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.
    Luthman J; Lindqvist E; Young D; Cowburn R
    Exp Brain Res; 1990; 83(1):85-95. PubMed ID: 1981564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
    Crawford CA; Rowlett JK; McDougall SA; Bardo MT
    Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
    Porceddu ML; Giorgi O; De Montis G; Mele S; Cocco L; Ongini E; Biggio G
    Life Sci; 1987 Aug; 41(6):697-706. PubMed ID: 2956472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo binding of SCH 39166: a D-1 selective antagonist.
    McQuade RD; Duffy RA; Coffin VL; Chipkin RE; Barnett A
    J Pharmacol Exp Ther; 1991 Apr; 257(1):42-9. PubMed ID: 1826927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.